388 related articles for article (PubMed ID: 38003445)
1. Unraveling the Janus-Faced Role of Autophagy in Hepatocellular Carcinoma: Implications for Therapeutic Interventions.
Nguyen TH; Nguyen TM; Ngoc DTM; You T; Park MK; Lee CH
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003445
[TBL] [Abstract][Full Text] [Related]
2. CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma.
Yao J; Wang J; Xu Y; Guo Q; Sun Y; Liu J; Li S; Guo Y; Wei L
Autophagy; 2022 Aug; 18(8):1879-1897. PubMed ID: 34890308
[TBL] [Abstract][Full Text] [Related]
3. Suppression of optineurin impairs the progression of hepatocellular carcinoma through regulating mitophagy.
Inokuchi S; Yoshizumi T; Toshima T; Itoh S; Yugawa K; Harada N; Mori H; Fukuhara T; Matsuura Y; Mori M
Cancer Med; 2021 Mar; 10(5):1501-1514. PubMed ID: 33600074
[TBL] [Abstract][Full Text] [Related]
4. Autophagy: Dual Response in the Development of Hepatocellular Carcinoma.
Yazdani HO; Huang H; Tsung A
Cells; 2019 Jan; 8(2):. PubMed ID: 30695997
[TBL] [Abstract][Full Text] [Related]
5. Autophagy orchestrates resistance in hepatocellular carcinoma cells.
Seydi H; Nouri K; Rezaei N; Tamimi A; Hassan M; Mirzaei H; Vosough M
Biomed Pharmacother; 2023 May; 161():114487. PubMed ID: 36963361
[TBL] [Abstract][Full Text] [Related]
6. Oxidative Stress-Driven Autophagy acROSs Onset and Therapeutic Outcome in Hepatocellular Carcinoma.
Ciccarone F; Castelli S; Ciriolo MR
Oxid Med Cell Longev; 2019; 2019():6050123. PubMed ID: 31205585
[TBL] [Abstract][Full Text] [Related]
7. Blocking Parkin/PINK1-mediated mitophagy sensitizes hepatocellular carcinoma cells to sanguinarine-induced mitochondrial apoptosis.
Su Q; Wang J; Liu F; Zhang Y
Toxicol In Vitro; 2020 Aug; 66():104840. PubMed ID: 32234456
[TBL] [Abstract][Full Text] [Related]
8. Investigating autophagy and intricate cellular mechanisms in hepatocellular carcinoma: Emphasis on cell death mechanism crosstalk.
Wang G; Jiang X; Torabian P; Yang Z
Cancer Lett; 2024 Apr; 588():216744. PubMed ID: 38431037
[TBL] [Abstract][Full Text] [Related]
9. Cepharanthine hydrochloride induces mitophagy targeting GPR30 in hepatocellular carcinoma (HCC).
Wang Y; Su GF; Huang ZX; Wang ZG; Zhou PJ; Fan JL; Wang YF
Expert Opin Ther Targets; 2020 Apr; 24(4):389-402. PubMed ID: 32106726
[No Abstract] [Full Text] [Related]
10. Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma.
Huang F; Wang BR; Wang YG
World J Gastroenterol; 2018 Nov; 24(41):4643-4651. PubMed ID: 30416312
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy.
Tang Y; Chen K; Luan X; Zhang J; Liu R; Zheng X; Xie S; Ke H; Zhang X; Chen W
Int J Oncol; 2020 Dec; 57(6):1368-1380. PubMed ID: 33174013
[TBL] [Abstract][Full Text] [Related]
12. Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma.
Chen Y; Chen HN; Wang K; Zhang L; Huang Z; Liu J; Zhang Z; Luo M; Lei Y; Peng Y; Zhou ZG; Wei Y; Huang C
J Hepatol; 2019 Jan; 70(1):66-77. PubMed ID: 30287340
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the Autophagy-lysosomal Pathway in Hepatocellular Carcinoma Using Small Molecules.
Lee YG; Jeon TI
Molecules; 2020 Mar; 25(7):. PubMed ID: 32235537
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in autophagy-induced hepatocellular carcinoma.
Zhou J; Zhang X; Tang H; Yu J; Zu X; Xie Z; Yang X; Hu J; Tan F; Li Q; Lei X
Clin Chim Acta; 2020 Jul; 506():1-8. PubMed ID: 32109431
[TBL] [Abstract][Full Text] [Related]
15. Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy.
Chang Z; Shi G; Jin J; Guo H; Guo X; Luo F; Song Y; Jia X
Int J Mol Med; 2013 Jun; 31(6):1449-56. PubMed ID: 23588698
[TBL] [Abstract][Full Text] [Related]
16. Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches.
Hashemi M; Nadafzadeh N; Imani MH; Rajabi R; Ziaolhagh S; Bayanzadeh SD; Norouzi R; Rafiei R; Koohpar ZK; Raei B; Zandieh MA; Salimimoghadam S; Entezari M; Taheriazam A; Alexiou A; Papadakis M; Tan SC
Cell Commun Signal; 2023 Feb; 21(1):32. PubMed ID: 36759819
[TBL] [Abstract][Full Text] [Related]
17. Multiple Roles of Autophagy in the Sorafenib Resistance of Hepatocellular Carcinoma.
Sun T; Liu H; Ming L
Cell Physiol Biochem; 2017; 44(2):716-727. PubMed ID: 29169150
[TBL] [Abstract][Full Text] [Related]
18. The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target.
Xue ST; Li K; Gao Y; Zhao LY; Gao Y; Yi H; Jiang JD; Li ZR
Autophagy; 2020 Oct; 16(10):1823-1837. PubMed ID: 31986961
[TBL] [Abstract][Full Text] [Related]
19. Suppression of DRP1‑mediated mitophagy increases the apoptosis of hepatocellular carcinoma cells in the setting of chemotherapy.
Ma M; Lin XH; Liu HH; Zhang R; Chen RX
Oncol Rep; 2020 Mar; 43(3):1010-1018. PubMed ID: 32020220
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors promote epithelial-mesenchymal transition in Hepatocellular Carcinoma
Xiao Q; Liu H; Wang HS; Cao MT; Meng XJ; Xiang YL; Zhang YQ; Shu F; Zhang QG; Shan H; Jiang GM
Theranostics; 2020; 10(22):10245-10261. PubMed ID: 32929346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
